Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

Journal of Applied Microbiology

Volumn 112, Issue 6, 2012, Pages 1266-1276

  Bottero, D ^a   Gaillard, M E ^a   Basile, L A ^a   Fritz, M ^a   Hozbor, D F ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Disease; Pertussis; Proteomic; Re emergence; Vaccine strains

Indexed keywords

BACTERIA; ELECTROPHORESIS; PROTEINS; STRAIN;

'CURRENT; GENOMICS ANALYSIS; GENOTYPIC CHARACTERIZATION; LATIN AMERICA; PERTUSSIS; PHENOTYPIC CHARACTERIZATION; PROTEOMICS; PULSE FIELD GEL ELECTROPHORESIS; RE-EMERGENCE; VACCINE STRAINS;

VACCINES;

MEMBRANE PROTEIN; PERTUSSIS VACCINE;

BACTERIUM; ELECTROKINESIS; GENE EXPRESSION; GENOMICS; GENOTYPE; IMMUNIZATION; PHENOTYPE; PROTEIN; PROTEOMICS; TOXIN; VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; DRUG FORMULATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOMICS; GENOTYPE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEOMICS; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AND CENTRAL AMERICA;

LATIN AMERICA;

BORDETELLA PERTUSSIS;

EID: 84860838811     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2012.05299.x     Document Type: Article

References (45)

1. Advani, A., Donnelly, D. and Hallander, H. (2004) Reference -system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol 42, 2890-2897.
2. Advani, A., Gustafsson, L., Ahren, C., Mooi, F.R. and Hallander, H.O. (2011) Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29, 3438-3442.
3. Altindis, E., Tefon, B.E., Yildirim, V., Ozcengiz, E., Becher, D., Hecker, M. and Ozcengiz, G. (2009) Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 27, 542-548.
4. Bart, M.J., van Gent, M., van der Heide, H.G., Boekhorst, J., Hermans, P., Parkhill, J. and Mooi, F.R. (2010) Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 11, 627.
5. Borisova, O., Kombarova, S.Y., Zakharova, N.S., van Gent, M., Aleshkin, V.A., Mazurova, I. and Mooi, F.R. (2007) Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 14, 234-238.
6. Bottero, D., Gaillard, M.E., Fingermann, M., Weltman, G., Fernandez, J., Sisti, F., Graieb, A., Roberts, R. et al. (2007) Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 14, 1490-1498.
7. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
8. Caro, V., Njamkepo, E., Van Amersfoorth, S.C., Mooi, F.R., Advani, A., Hallander, H.O., He, Q., Mertsola, J. et al. (2005) Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 7, 976-982.
9. Cassiday, P., Sanden, G., Heuvelman, K., Mooi, F., Bisgard, K.M. and Popovic, T. (2000) Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 182, 1402-1408.
10. Fennelly, N.K., Sisti, F., Higgins, S.C., Ross, P.J., van der Heide, H., Mooi, F.R., Boyd, A. and Mills, K.H. (2008) Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun 76, 1257-1266.
11. Fiett, J., Letowska, I., Gniadkowski, M. and Hryniewicz, W. (2003) The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J Microbiol Methods 55, 651-666.
12. Gaillard, M.E., Bottero, D., Castuma, C.E., Basile, L.A. and Hozbor, D. (2011) Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality. Infect Immun 79, 3677-3682.
13. van Gent, M., de Greeff, S.C., van der Heide, H.G. and Mooi, F.R. (2009) An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands. Vaccine 27, 1898-1903.
14. Gzyl, A., Augustynowicz, E., van Loo, I. and Slusarczyk, J. (2001) Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 20, 299-303.
15. Hardwick, T.H., Cassiday, P., Weyant, R.S., Bisgard, K.M. and Sanden, G.N. (2002a) Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis 8, 44-49.
16. Hardwick, T.H., Plikaytis, B., Cassiday, P.K., Cage, G., Peppler, M.S., Shea, D., Boxrud, D. and Sanden, G.N. (2002b) Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis. J Clin Microbiol 40, 811-816.
17. Heikkinen, E., Xing, D.K., Olander, R.M., Hytonen, J., Viljanen, M.K., Mertsola, J. and He, Q. (2008) Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 8, 162.
18. van Hemert, P.A. (1969) Specific properties of acid precipitated pertussis vaccine. Prog Immunobiol Stand 3, 297-301.
19. Hozbor, D., Mooi, F., Flores, D., Weltman, G., Bottero, D., Fossati, S., Lara, C., Gaillard, M.E. et al. (2009) Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 59, 225-231.
20. Kallonen, T. and He, Q. (2009) Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines 8, 863-875.
21. Kasuga, T., Nakase, Y., Ukishima, K. and Takatsu, K. (1954a) Studies on Haemophilis pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch Exp Med 27, 37-47.
22. Kasuga, T., Nakase, Y., Ukishima, K. and Takatsu, K. (1954b) Studies on Haemophilus pertussis. IV. Preventive potency of each phase organisms of H. pertussis in mice. Kitasato Arch Exp Med 27, 49-55.
23. Kasuga, T., Nakase, Y., Ukishima, K. and Takatsu, K. (1954c) Studies on Haemophilus pertussis. V. Relation between the phase of bacilli and the progress of the whooping-cough. Kitasato Arch Exp Med 27, 57-62.
24. King, A.J., Berbers, G., van Oirschot, H.F., Hoogerhout, P., Knipping, K. and Mooi, F.R. (2001) Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147, 2885-2895.
25. Kurova, N., Njamkepo, E., Brun, D., Tseneva, G. and Guiso, N. (2010) Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Res Microbiol 161, 810-815.
26. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
27. van Loo, I.H., Heuvelman, K.J., King, A.J. and Mooi, F.R. (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40, 1994-2001.
28. Lu, Z., Szafron, D., Greiner, R., Lu, P., Wishart, D.S., Poulin, B., Anvik, J., Macdonell, C. et al. (2004) Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics 20, 547-556.
29. Medhekar, B., Shrivastava, R., Mattoo, S., Gingery, M. and Miller, J.F. (2008) Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo. Mol Microbiol 71, 492-504.
30. Mooi, F.R. (2010) Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 10, 36-49.
31. Mooi, F.R., van Oirschot, H., Heuvelman, K., van der Heide, H.G., Gaastra, W. and Willems, R.J. (1998) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66, 670-675.
32. Mooi, F.R., Hallander, H., Wirsing von Konig, C.H., Hoet, B. and Guiso, N. (2000) Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19, 174-181.
33. Mooi, F.R., van Loo, I.H., van Gent, M., He, Q., Bart, M.J., Heuvelman, K.J., de Greeff, S.C., Diavatopoulos, D. et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15, 1206-1213.
34. Packard, E.R., Parton, R., Coote, J.G. and Fry, N.K. (2004) Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53, 355-365.
35. Pereira, A., Pereira, A.S., Moreira-Filho, C.A., Bando, S.Y. and Tambourgi, D.V. (2005) Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine. Vaccine 23, 4353-4358.
36. Riley, M. (1993) Functions of the gene products of Escherichia coli. Microbiol Rev 57, 862-952.
37. Schouls, L.M., van der Heide, H.G., Vauterin, L., Vauterin, P. and Mooi, F.R. (2004) Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186, 5496-5505.
38. Stainer, D.W. and Scholte, M.J. (1970) A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 63, 211-220.
39. Tefon, B.E., Maass, S., Ozcengiz, E., Becher, D., Hecker, M. and Ozcengiz, G. (2011) A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins. Vaccine 29, 3583-3589.
40. Tsang, R.S., Lau, A.K., Sill, M.L., Halperin, S.A., Van Caeseele, P., Jamieson, F. and Martin, I.E. (2004) Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 42, 5364-5367.
41. Van Loo, I.H. and Mooi, F.R. (2002) Changes in the Dutch Bordetella pertussis population in the first 20years after the introduction of whole-cell vaccines. Microbiology 148, 2011-2018.
42. World Health Organization, W. (2010) Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 85, 385-400.
43. Wu, Z., Zhang, W. and Lu, C. (2008) Immunoproteomic assay of surface proteins of Streptococcus suis serotype 9. FEMS Immunol Med Microbiol 53, 52-59.
44. Zhang, L., Xu, Y., Zhao, J., Kallonen, T., Cui, S., Hou, Q., Li, F., Wang, J. et al. (2010) Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis 16, 1695-1701.
45. Zhu, Y.Z., Cai, C.S., Zhang, W., Guo, H.X., Zhang, J.P., Ji, Y.Y., Ma, G.Y., Wu, J.L. et al. (2010) Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV). PLoS ONE 5, e13915.